Voice Therapy Methods for Dysphonia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests various methods of voice therapy to assess their effectiveness for individuals with voice problems. It targets those with muscle tension dysphonia (a voice issue from muscle strain) or benign vocal fold lesions (non-cancerous growths on the vocal cords). Participants will engage in different therapy approaches, including Deconstructing Voice Therapy, and monitor their progress over a year. Ideal candidates are non-smokers with these conditions, who have not recently undergone voice therapy or surgery, and are willing to attend sessions and use a smartphone for practice. As an unphased trial, this study allows participants to explore innovative therapy methods and contribute to advancing voice treatment options.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these voice therapy methods are safe for treating dysphonia?
Research has shown that both Non-Hierarchical and Hierarchical Conversation Training Therapies (CTT) are generally well-tolerated by individuals with voice issues such as muscle tension dysphonia and vocal fold lesions. Studies on these therapies have not reported any serious side effects, indicating safety for most individuals.
In past studies, patients who underwent these therapies reported improvements in voice quality without major negative effects. Specifically, they experienced better overall voice quality and less strain. This suggests that these therapies are likely safe and could be a good option for those considering participation in a clinical trial for voice problems.12345Why are researchers excited about this trial?
Researchers are excited about the Voice Therapy Methods for Dysphonia trial because it explores innovative approaches to voice therapy that differ from traditional methods like vocal exercises and surgery. This trial investigates two methods: Non-Hierarchical Conversation Training Therapy (CTT) and Hierarchical Conversation Training Therapy (CTT-H). These techniques emphasize conversation-based training, which could offer a more practical and engaging way for patients to improve their vocal function. By focusing on real-world communication, these therapies aim to enhance voice quality and patient outcomes more naturally and effectively than current standard treatments.
What evidence suggests that this trial's treatments could be effective for dysphonia?
This trial will compare two methods of Conversation Training Therapy (CTT) for individuals with muscle tension dysphonia (MTD) or non-cancerous vocal cord issues. Studies have shown that CTT can improve scores on the Voice Handicap Index–10, which measures the impact of voice problems on daily life. One arm of this trial will use Non-Hierarchical Conversation Training Therapy (CTT), employing natural conversation as the main treatment to help patients use their voices more effectively in everyday situations. Another arm will use Hierarchical Conversation Training Therapy (CTT-H), which organizes conversation tasks to enhance voice outcomes. Both methods rely on motor learning theory, which aids skill acquisition through natural practice. Early findings suggest these therapies might boost confidence and reduce restrictions for those with voice problems.16789
Who Is on the Research Team?
Amanda Gillespie, PhD
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for individuals with voice problems diagnosed as non-phonotraumatic vocal hyperfunction (primary muscle tension dysphonia) or phonotraumatic vocal hyperfunction (benign vocal fold lesions). Specific eligibility criteria are not provided, but typically include age, health status, and the severity of the condition.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Non-Hierarchical Conversation Training Therapy (CTT) or Hierarchical Conversation Training Therapy (CTT-H) over a 4-week period
Follow-up
Participants are monitored for voice outcomes and adherence to therapy at multiple intervals post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Deconstructing Voice Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator